Detalles de la búsqueda
1.
The impact of histologic subtype on primary site surgery in the management of metastatic lobular versus ductal breast cancer: a population based study from the National Cancer Database (NCDB).
Breast Cancer Res Treat;
203(2): 245-256, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37833450
2.
Oncologic Safety of Immediate Oncoplastic Surgery Compared with Standard Breast-Conserving Surgery for Patients with Invasive Lobular Carcinoma.
Ann Surg Oncol;
2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38713388
3.
Trust in prenatal exome sequencing for expectant families facing unexplained fetal anomalies.
Prenat Diagn;
44(3): 263-269, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38158591
4.
HER-2 low status in early-stage invasive lobular carcinoma of the breast: associated factors and outcomes in an institutional series.
Breast Cancer Res Treat;
199(2): 349-354, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37017812
5.
Quantifying hormone receptor status in lobular breast cancer in an institutional series: the relationship between estrogen and progesterone receptor status and outcomes.
Breast Cancer Res Treat;
202(2): 367-375, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37500962
6.
Successful Breast Conservation After Neoadjuvant Chemotherapy in Lobular Breast Cancer: The Role of Menopausal Status in Response to Treatment.
Ann Surg Oncol;
30(12): 7099-7106, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37561345
7.
Predictors of Early Versus Late Recurrence in Invasive Lobular Carcinoma of the Breast: Impact of Local and Systemic Therapy.
Ann Surg Oncol;
30(10): 5999-6006, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37464134
8.
Obesity and menopausal status impact the features and molecular phenotype of invasive lobular breast cancer.
Breast Cancer Res Treat;
191(2): 451-458, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34817747
9.
ASO Author Reflections: Patient, Tumor, and Treatment Characteristics Predict Early Versus Late Recurrence in Patients with Invasive Lobular Carcinoma of the Breast.
Ann Surg Oncol;
30(10): 6008-6009, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37460737
10.
ASO Visual Abstract: Successful Breast Conservation After Neoadjuvant Chemotherapy in Lobular Breast Cancer: The Role of Menopausal Status in Response to Treatment.
Ann Surg Oncol;
30(12): 7152, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37626250
11.
ASO Visual Abstract: Predictors of Early Versus Late Recurrence in Invasive Lobular Carcinoma of the Breast: Impact of Local and Systemic Therapy.
Ann Surg Oncol;
30(10): 6007, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37552350
12.
Roadmap to safety: a single center study of evidence-informed approach to placenta accreta spectrum.
Front Surg;
11: 1347549, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38511075
13.
The impact of histologic subtype on primary site surgery in the management of metastatic lobular versus ductal breast cancer: a population based study from the National Cancer Database.
Res Sq;
2023 Jul 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37503233
14.
Erratum: 53 The development of a multi-institutional prospective registry for patients with metastatic invasive lobular carcinoma: identifying new markers of disease progression - CORRIGENDUM.
J Clin Transl Sci;
7(1): e202, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37830005
15.
Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer.
NPJ Breast Cancer;
9(1): 88, 2023 Oct 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37884561
16.
Area Deprivation Index in Patients with Invasive Lobular Carcinoma of the Breast: Associations with Tumor Characteristics and Outcomes.
Cancer Epidemiol Biomarkers Prev;
32(8): 1107-1113, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37257200
17.
Loss of NECTIN1 triggers melanoma dissemination upon local IGF1 depletion.
Nat Genet;
54(12): 1839-1852, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36229674
18.
Modulation of the immune microenvironment of high-risk ductal carcinoma in situ by intralesional pembrolizumab injection.
NPJ Breast Cancer;
7(1): 59, 2021 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34035311
19.
Massively parallel reporter assays of melanoma risk variants identify MX2 as a gene promoting melanoma.
Nat Commun;
11(1): 2718, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32483191
20.
Human tumor genomics and zebrafish modeling identify SPRED1 loss as a driver of mucosal melanoma.
Science;
362(6418): 1055-1060, 2018 11 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-30385465